September 25, 2018

 

Immunotherapy for Breast Cancer-Hope Medical Group

Breast Cancer is a cancer that starts in the tissues of the breast. There are two main types of breast cancer:

. Ductal carcinoma starts in the tubes (ducts) that move milk from the breast to the nipple. Most breast cancers are of this type.

. Lobular carcinoma starts in the parts of the breast, called lobules, that produce milk.

In rare cases, breast cancer can start in other areas of the breast.

Breast cancer may be invasive or noninvasive. Invasive means it has spread from the milk duct or lobule to other tissues in the breast. Noninvasive means it has not yet invaded other breast tissue. Noninvasive breast cancer is called "in situ."

Ductal carcinoma in situ (DCIS), or intraductal carcinoma, is breast cancer in the lining of the milk ducts that has not yet invaded nearby tissues. It may progress to invasive cancer if untreated.

. Lobular carcinoma in situ (LCIS) is a marker for an increased risk of invasive cancer in the same or both breasts.

Many breast cancers are sensitive to the hormone estrogen. This means that estrogen causes the breast cancer tumor to grow. Such cancers have estrogen receptors on the surface of their cells. They are called estrogen receptor-positive cancer or ER-positive cancer.

Disadvantages of Mastectomy, Radiotherapy & Chemotherapy

The disadvantages of a mastectomy are, of course, that having an entire breast removed is very upsetting.

Chemotherapy works by interrupting cell division in cells that are multiplying quickly. Since cancer cells reproduce at an abnormally fast rate, they are affected by chemotherapy. Several cycles are needed to catch more cells, since not all of them will be dividing on the day you get chemotherapy. Unfortunately, other cells in your body also reproduce quickly enough to be affected by the treatment. Hair follicles shut down, which means your hair either falls out or does not grow. The linings of the mouth, stomach, and intestines also contain cells that multiply rapidly. These cells are disrupted by chemotherapy, which can cause mouth sores, a "burned tongue" sensation, nausea, constipation, hemorrhoids, and diarrhea.

The disadvantage of radiotherapy is also worry that the cancer will come back.

Non-surgical treatments


DC + CIK cells and how to effectively cure cancer

Today, breast tumors can be detected early and removed with advanced surgery and treatment, but current therapies cannot prevent or eradicate breast cancer after metastatic spread to distant organs. The prognosis is very poor if breast cancer spreads to the brain. As a shielded “sanctuary site,” the brain may harbor breast cancer cells which resist current treatments and can develop into satellite tumors, known as metastases, long after chemo-, radiation, or immuno- therapies have been applied. The patient’s situation can be managed in the clinic only for a few weeks or months before becoming fatal. 


Our DC+CIK cancer treatment provides new hope for patients, through an innovative approach based on stem cells, the body's own natural mechanism for healing and regeneration.
Cytokine-induced killer (CIK) cells are important immune cells, and dendritic cells (DC) can be induced to be co-cultured with CD3 + CD56 + (NKT) phenotype main groups of T-killer cells (DCCIK). Immunotherapy in cancer patients showed a broad spectrum of killing tumor cells, its function and use of exogenous split-mediated tumor cell material, tumor-associated antigen-activated DC, CIK cells co-cultured cells different, is not major histocompatibility complex (MHC) restricted, and there is a strong anti-tumor immune activity. It also significantly reduces the immune tolerance of cancer patients, a decrease of T suppressor cells (Treg1 immunosuppression and effectively prevent the generation of autoimmune disease in patients.

In short, DC+CIK cells in the human body's own immune system enhance and rebuild its immune system, automatically identify and track tumor cells, and transmit this information to patients own immune cells, promoting their activation and proliferate to eliminate residual metastatic lesions, prevent spread and recurrence of cancer and enhance immunity. This improves the quality of life of patients, ultimately prolonging the patients life for years.


Treatment Method :

Number of Injection - 8 units of high density DC+CIK cell (DC-CIK)

Type of Injection - Intravenous (IV) Injection x 6 times of high density DC+CIK cell (DC-CIK) (We may double the dosing and give 2 rounds each time.)

Treatment Period :

9 days

The payment includes:

DC+CIK cell implantation :
Physiotherapy and occupational therapy sessions, from Monday to Friday,
Traditional Chinese medicine
Accommodation for the patient AND for 1 or 2 accompanying family members.
General medical services ; Doctor's visits and examinations, laboratory tests, etc

Side effects:
None in over 20,000 cases treated worldwide.

Foreign patient services:

Our international department team helps our foreign patients handle all the communication aspects of getting medical treatment in a foreign country. Staff is ready to help with everything from communicating with the medical team, nurses, and caregivers to daily needs like shopping, going to the bank, or making visa arrangements. We also provide transportation from the airport to the hospital upon arrival and make all necessary arrangements for transportation to the airport upon completion of the treatment.

 For more information on stem cell immunotherapy for breast cancer, please complete a medical form here or visit http://hopestemcell.com/cancer-immunology

 

Free Medical Evaluation

 

International patients contact:

 

This email address is being protected from spambots. You need JavaScript enabled to view it.